The PE Ratio as of December 2025 (TTM) for Taiwan Bio Therapeutics Co., Ltd (6892.TWO) is -5.35

According to Taiwan Bio Therapeutics Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -5.35. This represents a change of -29.99% compared to the average of -7.64 of the last 4 quarters.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Historical PE Ratio (quarterly & annually)

How has 6892.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Taiwan Bio Therapeutics Co., Ltd over the last ten years is -7.96. The current -5.35 PE Ratio has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), 6892.TWO's PE Ratio was at its highest in in the December 2022 quarter at 0. The PE Ratio was at its lowest in in the December 2023 quarter at -14.01.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Taiwan Bio Therapeutics Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Average PE Ratio

How has 6892.TWO PE Ratio performed in the past?

The current PE Ratio of Taiwan Bio Therapeutics Co., Ltd (6892.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) PE Ratio vs. Peers

How is 6892.TWO’s PE Ratio compared to its peers?

Taiwan Bio Therapeutics Co., Ltd’s PE Ratio is greater than Intech Biopharm Corporation (-6.72), greater than TaiRx, Inc. (-17.86), greater than Steminent Biotherapeutics Inc. (-14.95), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.96), less than HeXun Biosciences Co., Ltd. (15.45), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-38.51), greater than GlycoNex Incorporation (-11.61), greater than Sinew Pharma Inc. (-19.44), greater than Sunny Pharmtech Inc. (-7.79), less than G&E Herbal Biotechnology Co., Ltd. (24.40),

Build a custom stock screener for Taiwan Bio Therapeutics Co., Ltd (6892.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiwan Bio Therapeutics Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taiwan Bio Therapeutics Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.